The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Abstract
The Ras-dependent extracellular signal-regulated kinase (ERK)1/2 mitogen-activated protein (MAP) kinase pathway plays a central role in cell proliferation control. In normal cells, sustained activation of ERK1/ERK2 is necessary for G1- to S-phase progression and is associated with induction of positive regulators of the cell cycle and inactivation of antiproliferative genes. In cells expressing activated Ras or Raf mutants, hyperactivation of the ERK1/2 pathway elicits cell cycle arrest by inducing the accumulation of cyclin-dependent kinase inhibitors. In this review, we discuss the mechanisms by which activated ERK1/ERK2 regulate growth and cell cycle progression of mammalian somatic cells. We also highlight the findings obtained from gene disruption studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The sustained activation of ERK1/2 is necessary for the progression from G 1 phase to S phase and is associated with the upregulation of proliferation-associated genes and the downregulation of antiproliferative genes ( 56 ).”
From Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration (2017) · cites this paper as [56]
Citations
Cites
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787 · cited 1×
“…and cellular energy status to modulate ribosome biogenesis and translation initiation (see Fingar and Blenis, 2004; Hay and Sonenberg, 2004; Wullschleger et al., 2006 for reviews). mTOR activity is negatively regulated by the tuberous sclerosis complex 1 (TSC1)/TSC2 heterodimer, which acts…”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 11×
“Oncogene Induction of D-type cyclins and assembly of cyclin D–Cdk4 complexes Various mechanisms have been proposed to explain how the ERK1/2 MAP kinase pathway regulates G1-phase progression, although a complete picture is yet to emerge.”
BackgroundInfluentialThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · cited 1×
“…from growth factors, nutrients and cellular energy status to modulate ribosome biogenesis and translation initiation (see Fingar and Blenis, 2004; Hay and Sonenberg, 2004; Wullschleger et al., 2006 for reviews). mTOR activity is negatively regulated by the tuberous sclerosis complex 1…”
BackgroundMitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034 · cited 2×
“MAP kinase pathways are evolutionarily conserved signaling modules by which cells transduce extracellular signals into intracellular responses (reviewed in Lewis et al., 1998; Widmann et al., 1999; Pearson et al., 2001).”
BackgroundMitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
WIDMANN, C., GIBSON, S., JARPE, M. B., & JOHNSON, G. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.143 · Cited by 2,729 · cited 1×
“MAP kinase pathways are evolutionarily conserved signaling modules by which cells transduce extracellular signals into intracellular responses (reviewed in Lewis et al., 1998; Widmann et al., 1999; Pearson et al., 2001).”
BackgroundA synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679 · cited 2×
“…inhibit the proliferation of various cell types, including fibroblasts, T lymphocytes, smooth muscle cells, hepatocytes and epithelial cell lines (Dudley et al., 1995; Seufferlein et al., 1996; Karpova et al., 1997; DeSilva et al., 1998; Williams et al., 1998; SeboltLeopold et al., 1999;…”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×
“The recent demonstration that ‘oncogene-induced senescence’ occurs in vivo and can be documented in pre-cancerous human melanocytic naevi (expressing B-Raf) or mouse lung adenomas (induced by K-Ras) has provided strong support for the physiological importance of this tumor suppression mechanism (Collado et al., 2005;…”
BackgroundCowley, S. (1994) · Cell · doi:10.1016/0092-8674(94)90133-3 · Cited by 1,966 · cited 3×
“Conversely, expression of constitutively active forms of MEK1 (Brunet et al., 1994; Cowley et al., 1994; Seger et al., 1994) relaxes growth factor dependency and enhances the rate of cell proliferation.”
BackgroundPagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817 · cited 1×
“One of the key mechanisms that regulates p27 abundance is proteolysis by the ubiquitin–proteasome pathway (Pagano et al., 1995). p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the…”
BackgroundSignal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759 · cited 2×
“MAP kinase pathways are evolutionarily conserved signaling modules by which cells transduce extracellular signals into intracellular responses (reviewed in Lewis et al., 1998; Widmann et al., 1999; Pearson et al., 2001).”
BackgroundWhitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543 · cited 1×
“Activation of ERK1/ERK2 by mitogens or conditionally active Raf-1 and MEK1 leads to the elevated expression of individual Fos and Jun family proteins (Hill and Treisman, 1995; Whitmarsh and Davis, 1996; Balmanno and Cook, 1999; Cook et al., 1999; Treinies et al., 1999).”
BackgroundSKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543 · cited 3×
“One of the key mechanisms that regulates p27 abundance is proteolysis by the ubiquitin–proteasome pathway (Pagano et al., 1995). p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the SCFSkp2 E3 ligase in comp…”
BackgroundSenescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 2×
“The recent demonstration that ‘oncogene-induced senescence’ occurs in vivo and can be documented in pre-cancerous human melanocytic naevi (expressing B-Raf) or mouse lung adenomas (induced by K-Ras) has provided strong support for the physiological importance of this tumor suppression mechanism (Collado et al., 2005;…”
BackgroundTo cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
The Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,422
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402 · cited 2×
“The transient accumulation of p21 likely contributes to the stabilization of cyclin D–Cdk4 complexes in G1 (LaBaer et al., 1997; Cheng et al., 1999; Bagui et al., 2003).”
BackgroundMultiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393 · cited 2×
“Activation of ERK1/ ERK2 markedly enhances c-Myc protein stability as a result of direct phosphorylation of Ser 62 (Sears et al., 2000).”
BackgroundCloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351 · cited 2×
“Stimulation of cells with mitogenic factors induces a transient accumulation of the Cdk inhibitor p21 in early G1phase by a p53-independent mechanism (Li et al., 1994; Michieli et al., 1994; Noda et al., 1994; Sheikh et al., 1994; Macleod et al., 1995).”
BackgroundPlacental development: Lessons from mouse mutants
Rossant, J., & Cross, J. C. (2001) · Nature Reviews Genetics · doi:10.1038/35080570 · Cited by 1,273 · cited 1×
“Given the primordial role of fibroblast growth factor 4 (FGF4) in promoting the proliferation of trophectoderm cells (Rossant and Cross, 2001) and the importance of ERK1/ERK2 MAP kinases in transducing signals from growth factor receptors, it has been suggested that ERK2 functions downstream of FGF…”
BackgroundThe extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
Yoon, S., & Seger, R. (2006) · Growth Factors · doi:10.1080/02699050500284218 · Cited by 1,273 · cited 1×
“ERK1/ERK2, which are expressed ubiquitously in mammalian cells, are multifunctional serine/threonine kinases that phosphorylate a vast array of substrates localized in all cellular compartments (Lewis et al., 1998; Pearson et al., 2001; Yoon and Seger, 2006).”
BackgroundPhosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268 · cited 2×
“The other study proposed that ERK1/ERK2 directly phosphorylate TSC2 on Ser 664 and inhibit its function by disrupting TSC1/TSC2 complex formation (Ma et al., 2005).”
BackgroundFingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247 · cited 1×
“…that integrates signals from growth factors, nutrients and cellular energy status to modulate ribosome biogenesis and translation initiation (see Fingar and Blenis, 2004; Hay and Sonenberg, 2004; Wullschleger et al., 2006 for reviews). mTOR activity is negatively regulated by the tuberous…”
BackgroundCyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway
Lavoie, J. N., L'Allemain, G., Brunet, A., Müller, R., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20608 · Cited by 1,211 · cited 1×
“Working downstream of Ras, activation of the ERK1/2 pathway was found to be both necessary and sufficient for transcriptional induction of the Cyclin D1 gene (Albanese et al., 1995; Lavoie et al., 1996).”
BackgroundSelf-citationc-MYC: more than just a matter of life and death
Pelengaris, S., Khan, M., & Evan, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc904 · Cited by 1,178 · cited 1×
“…of the Myc family of transcription factors that plays a central role in regulating cell growth, cell cycle progression and apoptosis (reviewed in Pelengaris et al., 2002). c-Myc heterodimerizes with its obligate partner Max to activate or repress transcription of a vast array of target genes…”
BackgroundThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 1×
“Rb phosphorylation disrupts its association with bound E2F family members, allowing the coordinated transcription of genes required for DNA replication (Weinberg, 1995; Harbour and Dean, 2000; Bracken et al., 2004).”
BackgroundCheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 2×
“The transient accumulation of p21 likely contributes to the stabilization of cyclin D–Cdk4 complexes in G1 (LaBaer et al., 1997; Cheng et al., 1999; Bagui et al., 2003).”
BackgroundTranscriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131 · cited 4×
“In addition, c-Myc also impacts profoundly on cell growth by activating genes Oncogene encoding ribosomal proteins and translation factors (Adhikary and Eilers, 2005), and by stimulating transcription of ribosomal RNA genes by Pol I (Arabi et al., 2005; Grandori et al., 2005).”
BackgroundInfluentialp53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119 · cited 2×
“Stimulation of cells with mitogenic factors induces a transient accumulation of the Cdk inhibitor p21 in early G1phase by a p53-independent mechanism (Li et al., 1994; Michieli et al., 1994; Noda et al., 1994; Sheikh et al., 1994; Macleod et al., 1995).”
BackgroundThe SCF ubiquitin ligase: insights into a molecular machine
Cardozo, T., & Pagano, M. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1471 · Cited by 1,114 · cited 2×
“Once active, Cdk2 also triggers the degradation of p27 through the SCFSkp2 ubiquitin ligase (Cardozo and Pagano, 2004).”
BackgroundTargeting the mitogen-activated protein kinase cascade to treat cancer
Sebolt-Leopold, J. S., & Herrera, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1503 · Cited by 1,108
Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity
Hill, C. S., & Treisman, R. (1995) · Cell · doi:10.1016/0092-8674(95)90403-4 · Cited by 1,012 · cited 1×
“Activation of ERK1/ERK2 by mitogens or conditionally active Raf-1 and MEK1 leads to the elevated expression of individual Fos and Jun family proteins (Hill and Treisman, 1995; Whitmarsh and Davis, 1996; Balmanno and Cook, 1999; Cook et al., 1999; Treinies et al., 1999).”
BackgroundMitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.
Pagès, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., & Pouysségur, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8319 · Cited by 984 · cited 2×
“The first demonstration of the direct involvement of ERK1/2 in the mitogenic response was provided by the findings that overexpression of ERK1 catalytically inactive mutants or antisense RNA inhibits the activation of endogenous ERK1/ERK2 and exerts a dominant-negative effect on fibroblast cell proliferation (Pages et…”
BackgroundSelf-citationGlobal analysis of protein phosphorylation in yeast
Ptacek, J., Devgan, G., Michaud, G., Zhu, H., Zhu, X., Fasolo, J., Guo, H., Jona, G., Breitkreutz, A., Sopko, R., et al. (2005) · Nature · doi:10.1038/nature04187 · Cited by 978
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
Waskiewicz, A. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1909 · Cited by 947 · cited 1×
“…mediated by the MAP kinase-activated protein kinase (MK) family members Mnk1/Mnk2, which are directly phosphorylated and activated by the MAP kinases ERK1/ERK2 and p38a/b in response to growth factors or stress stimuli (Fukunaga and Hunter, 1997; Waskiewicz et al., 1997, 1999; Ueda et al., 2004).”
BackgroundLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945 · cited 3×
“Expression of activated forms of Ras, Raf or MEK1 was shown to elicit cell cycle arrest in primary fibroblasts, Schwann cells, hepatocytes, T lymphocytes, keratinocytes, astrocytes and epithelial intestinal cells (Lloyd et al., 1997; Serrano et al., 1997; Lin et al., 1998; Tombes et al., 1998; Zhu et al., 1998; Chen e…”
BackgroundMolecular interpretation of ERK signal duration by immediate early gene products
Murphy, L. O., Smith, S., Chen, R.-H., Fingar, D. C., & Blenis, J. (2002) · Nature Cell Biology · doi:10.1038/ncb822 · Cited by 929 · cited 1×
“Recent findings have provided a molecular explanation for how immediateearly gene products sense the duration of the ERK1/2 signal in fibroblasts (Murphy et al., 2002, 2004).”
BackgroundCyclin E-CDK2 is a regulator of p27Kip1.
Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., & Clurman, B. E. (1997) · Genes & Development · doi:10.1101/gad.11.11.1464 · Cited by 911 · cited 2×
“p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the SCF E3 ligase in complex with the cofactor Cks1 (Carrano et al.”
BackgroundThe Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909 · cited 1×
“Finally, Cdk2 phosphorylates and inactivates the anaphase-promoting complex (APC)-activating subunit Cdh1, which targets a number of S-phase-promoting factors for degradation (Peters, 2002; Ang and Harper, 2004).”
Background(2006) · Cited by 879
Induction of WAF1/CIP1 by a p53-independent pathway.
Michieli, P., Chedid, M., Lin, D. P., Pierce, J. H., Mercer, W. E., & Givol, D. (1994) · PubMed · Cited by 845
Senescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826 · cited 3×
“Expression of activated forms of Ras, Raf or MEK1 was shown to elicit cell cycle arrest in primary fibroblasts, Schwann cells, hepatocytes, T lymphocytes, keratinocytes, astrocytes and epithelial intestinal cells (Lloyd et al., 1997; Serrano et al., 1997; Lin et al., 1998; Tombes et al., 1998; Zhu et al., 1998; Chen e…”
BackgroundColler, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823 · cited 3×
“Among the best-defined c-Myc targets that function directly in cell cycle control are cyclin D2 (Bouchard et al., 1999; Coller et al., 2000), Cdk4 (Hermeking et al.”
BackgroundTransforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803 · cited 3×
“The Cyclin D1 promoter contains a functional AP-1 binding site (Herber et al., 1994; Albanese et al., 1995) and one probable mechanism by which the ERK1/2 pathway impinges on Cyclin D1 transcription is by inducing the expression of AP-1 components.”
BackgroundTsvetkov, L. M., Yeh, K.-H., Lee, S.-J., Sun, H., & Zhang, H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80290-5 · Cited by 791 · cited 3×
“One of the key mechanisms that regulates p27 abundance is proteolysis by the ubiquitin–proteasome pathway (Pagano et al., 1995). p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the SCFSkp2 E3 ligase in comp…”
BackgroundRoux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., & Blenis, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405659101 · Cited by 750 · cited 4×
“One study showed that the serine/threonine kinase RSK1, a downstream substrate of ERK1/ ERK2, phosphorylates TSC2 in the conserved Cterminus of the protein (Ser 1798) to impair its antagonistic action on mTOR signaling (Roux et al., 2004).”
BackgroundInfluentialSize Control in Animal Development
Conlon, I., & Raff, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80563-2 · Cited by 743
Gene-Specific Regulation by General Translation Factors
Dever, T. E. (2002) · Cell · doi:10.1016/s0092-8674(02)00642-6 · Cited by 719 · cited 1×
“The current view is that phosphorylation of eIF4E does not lead to a global increase in mRNA Oncogene translation but rather enhances translation of specific mRNAs with extensive 50UTR structure (Dever, 2002; Mamane et al., 2004).”
Backgroundp45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
Sutterlüty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Müller, U., & Krek, W. (1999) · Nature Cell Biology · doi:10.1038/12027 · Cited by 700 · cited 3×
“One of the key mechanisms that regulates p27 abundance is proteolysis by the ubiquitin–proteasome pathway (Pagano et al., 1995). p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the SCFSkp2 E3 ligase in comp…”
BackgroundCdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690 · cited 1×
“Among the best-defined c-Myc targets that function directly in cell cycle control are cyclin D2 (Bouchard et al., 1999; Coller et al., 2000), Cdk4 (Hermeking et al., 2000), p21 (Claassen and Hann, 2000; Coller et al., 2000) and Cdc25A (Galaktionov et al., 1996; Zeller et al., 2003).”
BackgroundPhosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
Vlach, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5334 · Cited by 688 · cited 1×
“…by the ubiquitin–proteasome pathway (Pagano et al., 1995). p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the SCFSkp2 E3 ligase in complex with the cofactor Cks1 (Carrano et…”
Backgroundc-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N., & White, R. J. (2005) · Nature Cell Biology · doi:10.1038/ncb1224 · Cited by 665 · cited 2×
“In addition, c-Myc also impacts profoundly on cell growth by activating genes Oncogene encoding ribosomal proteins and translation factors (Adhikary and Eilers, 2005), and by stimulating transcription of ribosomal RNA genes by Pol I (Arabi et al., 2005; Grandori et al., 2005).”
BackgroundFukunaga, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1921 · Cited by 663 · cited 2×
“Phosphorylation of eIF4E on Ser 209 is mediated by the MAP kinase-activated protein kinase (MK) family members Mnk1/Mnk2, which are directly phosphorylated and activated by the MAP kinases ERK1/ERK2 and p38a/b in response to growth factors or stress stimuli (Fukunaga and Hunter, 1997; Waskiewicz et al., 1997, 1999; Ue…”
BackgroundDefective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice
Pagès, G., Guérin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., & Pouysségur, J. (1999) · Science · doi:10.1126/science.286.5443.1374 · Cited by 654 · cited 4×
“No Oncogene difference in the proliferation rate of ERK1-deficient embryonic fibroblasts was observed in a previous study (Pages et al., 1999), whereas RNAi silencing of ERK1 expression inhibited the proliferation of HeLa cells to the same extent as ERK2 silencing (Liu et al., 2004).”
BackgroundResultInfluentialWoods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639 · cited 5×
“Titration of activated Raf expression levels demonstrated that cells display bell-shaped dose–response curves; low Raf signal promotes cell cycle progression and S-phase entry, whereas high Raf activity inhibits DNA synthesis (Sewing et al., 1997; Woods et al., 1997).”
BackgroundInfluentialPocket proteins and cell cycle control
Cobrinik, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208619 · Cited by 601 · cited 1×
“Among the E2F-regulated genes are Cyclin E, Cyclin A2 and Emi1, which are key effectors of the G1/S transition in normal cells (Hsu et al., 2002; Cobrinik, 2005).”
BackgroundE2F target genes: unraveling the biology
Bracken, A. P., Ciro, M., Cocito, A., & Helin, K. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.06.006 · Cited by 576 · cited 1×
“Rb phosphorylation disrupts its association with bound E2F family members, allowing the coordinated transcription of genes required for DNA replication (Weinberg, 1995; Harbour and Dean, 2000; Bracken et al., 2004).”
BackgroundHow Cells Coordinate Growth and Division
Jorgensen, P., & Tyers, M. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.027 · Cited by 571 · cited 1×
“In proliferating cells, cell growth is coordinated with the cell division cycle to ensure that on average each cell division is accompanied by a doubling in mass in order to maintain cell size (Jorgensen and Tyers, 2004).”
BackgroundMayer, C., & Grummt, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209883 · Cited by 568 · cited 1×
“ERK1/ ERK2 are also predicted to regulate the synthesis of ribosomal RNA and other ribosomal components indirectly via activation of mTOR signaling (Mayer and Grummt, 2006) and stabilization of c-Myc (see below).”
BackgroundUeda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S., & Fukunaga, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6539-6549.2004 · Cited by 507 · cited 3×
“In agreement with this idea, no change in global protein synthesis was observed in Mnk1/Mnk2-deficient embryonic fibroblasts, despite complete elimination of eIF4E phosphorylation (Ueda et al., 2004).”
BackgroundDirect induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
Bouchard, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5321 · Cited by 502 · cited 2×
“Among the best-defined c-Myc targets that function directly in cell cycle control are cyclin D2 (Bouchard et al., 1999; Coller et al., 2000), Cdk4 (Hermeking et al.”
BackgroundCheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1091 · Cited by 496 · cited 4×
“…signaling by synthetic MEK1/2 inhibitors or dominant-negative ERK2, or after conditional activation of the pathway by activated Raf-1 or MEK1 (Sewing et al., 1997; Takuwa and Takuwa, 1997; Weber et al., 1997a; Cheng et al., 1998; Ladha et al., 1998; Chen et al., 1999; Tetsu and McCormick, 2003).”
BackgroundResultInfluentialRheb fills a GAP between TSC and TOR
Manning, B. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.003 · Cited by 483 · cited 2×
“…2004; Hay and Sonenberg, 2004; Wullschleger et al., 2006 for reviews). mTOR activity is negatively regulated by the tuberous sclerosis complex 1 (TSC1)/TSC2 heterodimer, which acts as a GTPase activating protein (GAP) for the small GTPase Rheb (Manning and Cantley, 2003; Corradetti and Guan, 2006).”
BackgroundZeller, K. I., Jegga, A. G., Aronow, B. J., O'Donnell, K. A., & Dang, C. V. (2003) · Genome Biology · doi:10.1186/gb-2003-4-10-r69 · Cited by 482 · cited 3×
“Among the best-defined c-Myc targets that function directly in cell cycle control are cyclin D2 (Bouchard et al., 1999; Coller et al., 2000), Cdk4 (Hermeking et al., 2000), p21 (Claassen and Hann, 2000; Coller et al., 2000) and Cdc25A (Galaktionov et al., 1996; Zeller et al., 2003).”
Backgroundc-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
Arabi, A., Wu, S., Ridderstråle, K., Bierhoff, H., Shiue, C., Fatyol, K., Fahlén, S., Hydbring, P., Söderberg, O., Grummt, I., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1225 · Cited by 472 · cited 2×
“In addition, c-Myc also impacts profoundly on cell growth by activating genes Oncogene encoding ribosomal proteins and translation factors (Adhikary and Eilers, 2005), and by stimulating transcription of ribosomal RNA genes by Pol I (Arabi et al., 2005; Grandori et al., 2005).”
BackgroundIdentification of CDK4 as a target of c-MYC
Hermeking, H., Rago, C., Schuhmacher, M., Li, Q., Barrett, J. F., Obaya, A. J., O'Connell, B. C., Mateyak, M. K., Tam, W., Kohlhuber, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050586197 · Cited by 471 · cited 2×
“Among the best-defined c-Myc targets that function directly in cell cycle control are cyclin D2 (Bouchard et al., 1999; Coller et al., 2000), Cdk4 (Hermeking et al., 2000), p21 (Claassen and Hann, 2000; Coller et al., 2000) and Cdc25A (Galaktionov et al., 1996; Zeller et al., 2003).”
BackgroundWaskiewicz, A. J., Johnson, J. C., Penn, B., Mahalingam, M., Kimball, S. R., & Cooper, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1871 · Cited by 469 · cited 1×
“…mediated by the MAP kinase-activated protein kinase (MK) family members Mnk1/Mnk2, which are directly phosphorylated and activated by the MAP kinases ERK1/ERK2 and p38a/b in response to growth factors or stress stimuli (Fukunaga and Hunter, 1997; Waskiewicz et al., 1997, 1999; Ueda et al., 2004).”
BackgroundThe cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27
Ganoth, D., Bornstein, G., Ko, T. K., Larsen, B., Tyers, M., Pagano, M., & Hershko, A. (2001) · Nature Cell Biology · doi:10.1038/35060126 · Cited by 467 · cited 3×
“One of the key mechanisms that regulates p27 abundance is proteolysis by the ubiquitin–proteasome pathway (Pagano et al., 1995). p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the SCFSkp2 E3 ligase in comp…”
BackgroundProliferation of cancer cells despite CDK2 inhibition
Tetsu, O., & McCormick, F. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 466 · cited 3×
“Although ERK1/2 signaling has been mainly associated with the induction of cyclin D1, there are a few reports implicating this pathway in the regulation of cyclin D2 (Dey et al., 2000; Piatelli et al., 2002) and cyclin D3 (Tetsu and McCormick, 2003) expression.”
BackgroundResultHigh-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1
Sewing, A., Wiseman, B., Lloyd, A. C., & Land, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5588 · Cited by 462 · cited 5×
“In contrast, other studies failed to document any significant change in p27 levels following inhibition of ERK1/2 signaling by synthetic MEK1/2 inhibitors or dominant-negative ERK2, or after conditional activation of the pathway by activated Raf-1 or MEK1 (Sewing et al., 1997; Takuwa and Takuwa, 1997; Weber et al., 19…”
BackgroundResultInfluentialMammalian Pyrimidine Biosynthesis: Fresh Insights into an Ancient Pathway
Evans, D. R., & Guy, H. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400007200 · Cited by 459 · cited 4×
“In addition to proteins, cell growth is associated with the upregulation of de novo pyrimidine biosynthesis to meet the increased demand in nucleotides (Evans and Guy, 2004).”
BackgroundInfluentialIntegrating the MAP kinase signal into the G1 phase cell cycle machinery
Roovers, K., & Assoian, R. K. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<818::aid-bies7>3.0.co;2-6 · Cited by 458 · cited 2×
“These studies have led to a model that integrates the amplitude and duration of ERK1/2 activity with cell cycle progression (Roovers and Assoian, 2000).”
BackgroundeIF4E – from translation to transformation
Mamane, Y., Petroulakis, E., Rong, L., Yoshida, K., Ler, L. W., & Sonenberg, N. (2004) · Oncogene · doi:10.1038/sj.onc.1207549 · Cited by 449 · cited 2×
“The current view is that phosphorylation of eIF4E does not lead to a global increase in mRNA Oncogene translation but rather enhances translation of specific mRNAs with extensive 50UTR structure (Dever, 2002; Mamane et al., 2004).”
BackgroundRossomando, A. J., Payne, D. M., Weber, M. J., & Sturgill, T. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6940 · Cited by 429 · cited 1×
“This pair of tyrosine phosphorylated proteins was later shown to correspond to the activated forms of two MAP-2/myelin basic protein (MBP) kinases characterized previously and referred to as p42mapk (ERK2) and p44mapk (ERK1) (Rossomando et al., 1989, 1991).”
BackgroundERK Activation Mediates Cell Cycle Arrest and Apoptosis after DNA Damage Independently of p53
Tang, D., Wu, D., Hirao, A., Lahti, J. M., Liu, L., Mazza, B., Kidd, V. J., Mak, T. W., & Ingram, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111598200 · Cited by 422 · cited 1×
“The ERK1/2 pathway may also be involved in the G2 DNA damage checkpoint response (Abbott and Holt, 1999; Tang et al., 2002; Yan et al., 2005).”
BackgroundWEBER, J. D., RABEN, D. M., PHILLIPS, P. J., & BALDASSARE, J. J. (1997) · Biochemical Journal · doi:10.1042/bj3260061 · Cited by 406 · cited 3×
“These early observations were confirmed by several laboratories using different cellular models (Cook and McCormick, 1996; Weber et al., 1997b; Talarmin et al., 1999; Jones and Kazlauskas, 2001), allowing the generalization of the model.”
BackgroundResultRousseau, D., Kaspar, R., Rosenwald, I., Gehrke, L., & Sonenberg, N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1065 · Cited by 399 · cited 3×
“On the other hand, overexpression of eIF4E had no significant effect on the polysomal distribution of cyclin D1 mRNA (Rosenwald et al., 1995; Rousseau et al., 1996).”
BackgroundUpstream of the mammalian target of rapamycin: do all roads pass through mTOR?
Corradetti, M. N., & Guan, K.-L. (2006) · Oncogene · doi:10.1038/sj.onc.1209885 · Cited by 386 · cited 1×
“…2004; Hay and Sonenberg, 2004; Wullschleger et al., 2006 for reviews). mTOR activity is negatively regulated by the tuberous sclerosis complex 1 (TSC1)/TSC2 heterodimer, which acts as a GTPase activating protein (GAP) for the small GTPase Rheb (Manning and Cantley, 2003; Corradetti and Guan, 2006).”
BackgroundAn essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development
Saba‐El‐Leil, M. K., Vella, F. D. J., Vernay, B., Voisin, L., Chen, L., Labrecque, N., Ang, S., & Meloche, S. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor939 · Cited by 366 · cited 3×
“Analysis of chimeric embryos demonstrated that Erk2 functions cell autonomously in extra-embryonic lineages for the development of the ectoplacental cone and extra-embryonic ectoderm (Saba-El-Leil et al., 2003).”
BackgroundSelf-citationCell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
Li, Y., Jenkins, C. W., Nichols, M. A., & Xiong, Y. (1994) · PubMed · Cited by 358
Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway
Pumiglia, K. M., & Decker, S. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.448 · Cited by 356 · cited 1×
“…shown that strong activation of ERK1/ERK2 by conditionally active Ras or Raf causes cell cycle arrest in established cell lines by inducing the expression of the Cdk inhibitor p21 (Pumiglia and Decker, 1997; Sewing et al., 1997; Woods et al., 1997; Kerkhoff and Rapp, 1998; Tombes et al., 1998).”
BackgroundA CDK-Independent Function of Mammalian Cks1
Spruck, C., Strohmaier, H., Watson, M., Smith, A. P. L., Ryan, A., Krek, W., & Reed, S. I. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00210-6 · Cited by 356 · cited 3×
“One of the key mechanisms that regulates p27 abundance is proteolysis by the ubiquitin–proteasome pathway (Pagano et al., 1995). p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the SCFSkp2 E3 ligase in comp…”
BackgroundMurphy, L. O., MacKeigan, J. P., & Blenis, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.144-153.2004 · Cited by 336 · cited 3×
“Activation of ERK1/ ERK2 markedly enhances c-Myc protein stability as a result of direct phosphorylation of Ser 62 (Sears et al., 2000). c-Myc contains a DEF domain that is required for the full phosphorylation of Ser 62 in response to growth factors (Murphy et al., 2004).”
BackgroundEbisuya, M., Kondoh, K., & Nishida, E. (2005) · Journal of Cell Science · doi:10.1242/jcs.02505 · Cited by 331 · cited 2×
“Not only the duration, but also the magnitude of the ERK1/2 signal plays a key role in determining the final cellular outcome of this pathway (reviewed in Roovers and Assoian, 2000; Ebisuya et al., 2005).”
BackgroundE2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1
Hsu, J. Y., Reimann, J. D. R., Sørensen, C. S., Lukas, J., & Jackson, P. K. (2002) · Nature Cell Biology · doi:10.1038/ncb785 · Cited by 331 · cited 1×
“Among the E2F-regulated genes are Cyclin E, Cyclin A2 and Emi1, which are key effectors of the G1/S transition in normal cells (Hsu et al., 2002; Cobrinik, 2005).”
BackgroundThe Role of Erk1 and Erk2 in Multiple Stages of T Cell Development
Fischer, A. M., Katayama, C. D., Pagès, G., Pouysségur, J., & Hedrick, S. M. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.013 · Cited by 329
Self-citationExtracellular signal-regulated kinase 2 is necessary for mesoderm differentiation
Yao, Y., Li, W., Wu, J., Germann, U. A., Su, M. S. S., Kuida, K., & Boucher, D. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134254100 · Cited by 323 · cited 1×
“Disruption of the Erk2 gene leads to early embryonic lethality (Hatano et al., 2003; Saba-El-Leil et al., 2003; Yao et al., 2003).”
BackgroundInducible regulatory elements in the human cyclin D1 promoter.
Herber, B., Truss, M., Beato, M., & Müller, R. (1994) · PubMed · Cited by 309
Does phosphorylation of the cap‐binding protein eIF4E play a role in translation initiation?
Scheper, G. C., & Proud, C. G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03291.x · Cited by 308 · cited 1×
“The functional impact of eIF4E phosphorylation is not clear and has been a subject of debate (Scheper and Proud, 2002).”
BackgroundEssential role for ERK2 mitogen‐activated protein kinase in placental development
Hatano, N., Mori, Y., Oh‐hora, M., Kosugi, A., Fujikawa, T., Nakai, N., Niwa, H., Miyazaki, J., Hamaoka, T., & Ogata, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00680.x · Cited by 296 · cited 1×
“Disruption of the Erk2 gene leads to early embryonic lethality (Hatano et al., 2003; Saba-El-Leil et al., 2003; Yao et al., 2003).”
BackgroundInduction of cyclin D1 overexpression by activated ras.
Filmus, J., Robles, A. I., Shi, W., Wong, M. J. H., Colombo, L. L., & Conti, C. J. (1994) · PubMed · Cited by 295
DeSilva, D. R., Jones, E. A., Favata, M. F., Jaffee, B. D., Magolda, R. L., Trzaskos, J. M., & Scherle, P. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4175 · Cited by 295 · cited 2×
“Similarly, treatment with synthetic MEK1/2 inhibitors, which prevents activation of ERK1/ERK2, was reported to inhibit the proliferation of various cell types, including fibroblasts, T lymphocytes, smooth muscle cells, hepatocytes and epithelial cell lines (Dudley et al., 1995; Seufferlein et al., 1996; Karpova et al.…”
BackgroundMeloche, S. (1992) · Molecular Endocrinology · doi:10.1210/me.6.5.845 · Cited by 290 · cited 3×
“…that mitogens induce a biphasic activation of ERK1 and ERK2 in fibroblasts, with a rapid and strong burst of kinase activity peaking at 5–10 min followed by a second wave of lower but sustained activity that persists throughout the G1 phase (Kahan et al., 1992; Meloche et al., 1992; Meloche, 1995).”
BackgroundSelf-citationLiu, J.-J., Chao, J.-R., Jiang, M.-C., Ng, S.-Y., Yen, J. J.-Y., & Yang-Yen, H.-F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3654 · Cited by 275 · cited 1×
“Early studies showed that expression of activated Ras is sufficient to induce the accumulation of cyclin D1 in different cell types (Filmus et al., 1994; Albanese et al., 1995; Liu et al., 1995; Arber et al., 1996; Winston et al., 1996).”
BackgroundRosenwald, I. B., Kaspar, R., Rousseau, D., Gehrke, L., Leboulch, P., Chen, J.-J., Schmidt, E. V., Sonenberg, N., & London, I. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21176 · Cited by 269 · cited 1×
“On the other hand, overexpression of eIF4E had no significant effect on the polysomal distribution of cyclin D1 mRNA (Rosenwald et al., 1995; Rousseau et al., 1996).”
BackgroundSale, E. M., Atkinson, P. G., & Sale, G. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07046.x · Cited by 266 · cited 2×
“…showed that overexpression of interfering mutants of MEK1 (Cowley et al., 1994; Seger et al., 1994), incubation with ERK2 antisense oligonucleotide (Sale et al., 1995) or expression of active MAP kinase phosphatase 1 (MKP-1/DUSP1) (Sun et al., 1994; Brondello et al., 1995) inhibits the induction…”
BackgroundTalarmin, H., Rescan, C., Cariou, S., Glaise, D., Zanninelli, G., Bilodeau, M., Loyer, P., Guguen-Guillouzo, C., & Baffet, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6003 · Cited by 265 · cited 4×
“The ERK1/2 signaling pathway has also been implicated in the regulation of the G2/M transition and mitosis in somatic cells.”
BackgroundInfluentialBrunet, A., Pagès, G., & Pouysségur, J. (1994) · PubMed · Cited by 262
Self-citationGrowth-factor-dependent mitogenesis requires two distinct phases of signalling
Jones, S. M., & Kazlauskas, A. (2001) · Nature Cell Biology · doi:10.1038/35055073 · Cited by 262 · cited 6×
“Careful temporal dissection of the signaling events required for cells to move from G0 through G1 and into S phase has revealed that accumulation of phosphatidylinositol-3-OH kinase (PI(3)K) lipid products is important for late G1 progression (Jones and Kazlauskas, 2001).”
BackgroundResultInfluentialActivation of the Protein Kinase p38 in the Spindle Assembly Checkpoint and Mitotic Arrest
Takenaka, K., Moriguchi, T., & Nishida, E. (1998) · Science · doi:10.1126/science.280.5363.599 · Cited by 261 · cited 2×
“…that ERK1/ERK2 are phosphorylated/activated during G2/M (Tamemoto et al., 1992; Edelmann et al., 1996; Wright et al., 1999; Roberts et al., 2002), others concluded that the kinases are inactivated in mitosis (Takenaka et al., 1998; Gomez-Cambronero, 1999; Hayne et al., 2000; Harding et al., 2003).”
BackgroundYamamoto, T., Ebisuya, M., Ashida, F., Okamoto, K., Yonehara, S., & Nishida, E. (2006) · Current Biology · doi:10.1016/j.cub.2006.04.044 · Cited by 259 · cited 2×
“A recent gene profiling analysis has identified a set of 173 genes that are downregulated by an ERK1/2-dependent mechanism during G1-phase progression (Yamamoto et al., 2006).”
BackgroundTopisirovic, I., Ruiz-Gutierrez, M., & Borden, K. L. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2677 · Cited by 257 · cited 1×
“Mutation of Ser 209 or treatment with the synthetic inhibitor of Mnk1/Mnk2 CGP57380 markedly reduced the nuclear export of cyclin D1 mRNA by eIF4E, demonstrating the importance of phosphorylation in this process (Topisirovic et al., 2004).”
BackgroundClaassen, G. F., & Hann, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150006697 · Cited by 256 · cited 1×
“Among the best-defined c-Myc targets that function directly in cell cycle control are cyclin D2 (Bouchard et al., 1999; Coller et al., 2000), Cdk4 (Hermeking et al., 2000), p21 (Claassen and Hann, 2000; Coller et al., 2000) and Cdc25A (Galaktionov et al., 1996; Zeller et al., 2003).”
BackgroundStefanovsky, V. Y., Pelletier, G., Hannan, R., Gagnon-Kugler, T., Rothblum, L. I., & Moss, T. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00384-7 · Cited by 242 · cited 1×
“Activation of the ERK1/2 pathway by growth factors or conditionally active Raf-1 induces an immediate increase in ribosomal RNA transcription, whereas inactivation of the pathway by MEK1/2 inhibitors suppresses basal and stimulated ribosomal transcription (Stefanovsky et al., 2001).”
BackgroundKahan, C., Seuwen, K., Meloche, S., & Pouysségur, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42220-x · Cited by 234 · cited 1×
“…of various cell types, including fibroblasts, T lymphocytes, smooth muscle cells, hepatocytes and epithelial cell lines (Dudley et al., 1995; Seufferlein et al., 1996; Karpova et al., 1997; DeSilva et al., 1998; Williams et al., 1998; SeboltLeopold et al., 1999; Talarmin et al., 1999).”
BackgroundSelf-citationMEK1-ERK2 Signaling Pathway Protects Myocardium From Ischemic Injury In Vivo
Lips, D. J., Bueno, O. F., Wilkins, B. J., Purcell, N. H., Kaiser, R. A., Lorenz, J. N., Voisin, L., Saba-El-Leil, M. K., Meloche, S., Pouysségur, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127126.73759.23 · Cited by 233 · cited 1×
“Early studies showed that expression of activated Ras is sufficient to induce the accumulation of cyclin D1 in different cell types (Filmus et al., 1994; Albanese et al., 1995; Liu et al., 1995; Arber et al., 1996; Winston et al., 1996).”
BackgroundSelf-citationRegulation of carbamoyl phosphate synthetase by MAP kinase
Graves, L. M., Guy, H. I., Kozlowski, P., Huang, M., Lazarowski, E., Pope, R. M., Collins, M. A., Dahlstrand, E. N., Earp, H. S., & Evans, D. R. (2000) · Nature · doi:10.1038/35002111 · Cited by 232 · cited 1×
“Mitogenic stimulation of cells induces the phosphorylation of CAD and allosterically activates the CPSase domain by an MEK1/2-dependent mechanism (Graves et al., 2000).”
BackgroundBalmanno, K., & Cook, S. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202647 · Cited by 227 · cited 3×
“As for entry into S phase, sustained activation of ERK1/ERK2 is required for the continued expression of cyclin D1 in G1 phase (Weber et al., 1997b; Balmanno and Cook, 1999; Roovers et al., 1999).”
BackgroundShapiro, P. S., Vaisberg, E., Hunt, A. J., Tolwinski, N. S., Whalen, A. M., McIntosh, J. R., & Ahn, N. G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.6.1533 · Cited by 224 · cited 8×
“Oncogene Induction of D-type cyclins and assembly of cyclin D–Cdk4 complexes Various mechanisms have been proposed to explain how the ERK1/2 MAP kinase pathway regulates G1-phase progression, although a complete picture is yet to emerge.”
InfluentialCooperating oncogenes converge to regulate cyclin/cdk complexes.
Lloyd, A. C., Obermüller, F., Staddon, S., Barth, C. F., McMahon, M., & Land, H. (1997) · Genes & Development · doi:10.1101/gad.11.5.663 · Cited by 224 · cited 2×
“Expression of activated forms of Ras, Raf or MEK1 was shown to elicit cell cycle arrest in primary fibroblasts, Schwann cells, hepatocytes, T lymphocytes, keratinocytes, astrocytes and epithelial intestinal cells (Lloyd et al., 1997; Serrano et al., 1997; Lin et al., 1998; Tombes et al., 1998; Zhu et al., 1998; Chen e…”
BackgroundZecevic, M., Catling, A. D., Eblen, S. T., Renzi, L., Hittle, J. C., Yen, T. J., Gorbsky, G. J., & Weber, M. J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.6.1547 · Cited by 218 · cited 1×
“Immunofluorescence studies with phospho-specific antibodies also suggested that ERK1/ERK2 and MEK1/MEK2 are active in mitosis and localized at kinetochores, spindle poles and midbody Oncogene (Shapiro et al., 1998; Zecevic et al., 1998; Willard and Crouch, 2001; Liu et al., 2004).”
Seger, R., Seger, D., Reszka, A. A., Munar, E. S., Eldar-Finkelman, H., Dobrowolska, G., Jensen, A. M., Campbell, J. S., Fischer, E. H., & Krebs, E. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47305-x · Cited by 216 · cited 2×
“Conversely, expression of constitutively active forms of MEK1 (Brunet et al., 1994; Cowley et al., 1994; Seger et al., 1994) relaxes growth factor dependency and enhances the rate of cell proliferation.”
BackgroundInhibition of Ras-Induced DNA Synthesis by Expression of the Phosphatase MKP-1
Sun, H., Tonks, N. K., & Bar-Sagi, D. (1994) · Science · doi:10.1126/science.7939666 · Cited by 214 · cited 1×
“…by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the SCFSkp2 E3 ligase in complex with the cofactor Cks1 (Carrano et al., 1999; Sutterluty et al., 1999; Tsvetkov et al., 1999; Ganoth et al., 2001; Spruck et al., 2001).”
BackgroundRoovers, K., Davey, G., Zhu, X., Bottazzi, M. E., & Assoian, R. K. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.10.3197 · Cited by 212 · cited 2×
“As for entry into S phase, sustained activation of ERK1/ERK2 is required for the continued expression of cyclin D1 in G1 phase (Weber et al., 1997b; Balmanno and Cook, 1999; Roovers et al., 1999).”
BackgroundERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially
Vantaggiato, C., Formentini, I., Bondanza, A., Bonini, C., Naldini, L., & Brambilla, R. (2006) · Journal of Biology · doi:10.1186/jbiol38 · Cited by 207 · cited 2×
“Intriguingly, it has been recently suggested that ERK1 acts as a negative regulator of cell proliferation in fibroblasts by restraining ERK2-dependent signaling (Vantaggiato et al., 2006).”
BackgroundCip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development
Nakayama, K.-I., & Nakayama, K. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199812)20:12<1020::aid-bies8>3.0.co;2-d · Cited by 205 · cited 1×
“The Cdk inhibitor p27 acts as a primary negative regulator of cell proliferation in a variety of cell types (Nakayama and Nakayama, 1998).”
BackgroundeIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′UTR
Culjkovic, B., Topisirovic, I., Skrabanek, L., Ruiz-Gutierrez, M., & Borden, K. L. B. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501019 · Cited by 204 · cited 2×
“, 2002) by a mechanism involving an 100-nucleotide sequence in the 30 UTR of cyclin D1 mRNA (Culjkovic et al., 2005).”
BackgroundRegulation of the cell cycle machinery by oncogenic ras.
Winston, J. T., Coats, S., Wang, Y.-Z., & Pledger, W. J. (1996) · PubMed · Cited by 198
Kawada, M., Yamagoe, S., Murakami, Y., Suzuki, K., Mizuno, S., & Uehara, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1201228 · Cited by 196 · cited 2×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et a…”
BackgroundWeber, J. D., Hu, W., Jefcoat, S. C., Raben, D. M., & Baldassare, J. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.32966 · Cited by 193 · cited 3×
“These early observations were confirmed by several laboratories using different cellular models (Cook and McCormick, 1996; Weber et al., 1997b; Talarmin et al., 1999; Jones and Kazlauskas, 2001), allowing the generalization of the model.”
BackgroundResultRegulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway.
Liu, Y., Martindale, J. L., Gorospe, M., & Holbrook, N. J. (1996) · PubMed · Cited by 192
Sheikh, M. S., Li, X. S., Chen, J. C., Shao, Z. M., Ordóñez, J. V., & Fontana, J. A. (1994) · PubMed · Cited by 191
Treinies, I., Paterson, H. F., Hooper, S., Wilson, R., & Marshall, C. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.321 · Cited by 189 · cited 6×
“Some studies have reported that overexpression of activated MEK1 in quiescent fibroblasts is sufficient to cause S-phase entry (Cowley et al., 1994; Gotoh et al., 1999; Treinies et al., 1999).”
BackgroundInfluentialTOMBES, M. R., AUER, L. K., MIKKELSEN, R., VALERIE, K., WYMANN, P. M., MARSHALL, J. C., MCMAHON, M., & DENT, P. (1998) · Biochemical Journal · doi:10.1042/bj3301451 · Cited by 186 · cited 4×
“Expression of activated forms of Ras, Raf or MEK1 was shown to elicit cell cycle arrest in primary fibroblasts, Schwann cells, hepatocytes, T lymphocytes, keratinocytes, astrocytes and epithelial intestinal cells (Lloyd et al., 1997; Serrano et al., 1997; Lin et al., 1998; Tombes et al., 1998; Zhu et al., 1998; Chen e…”
BackgroundInfluentialCook, S. J., Aziz, N., & McMahon, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.330 · Cited by 183 · cited 2×
“Activation of ERK1/ERK2 by mitogens or conditionally active Raf-1 and MEK1 leads to the elevated expression of individual Fos and Jun family proteins (Hill and Treisman, 1995; Whitmarsh and Davis, 1996; Balmanno and Cook, 1999; Cook et al., 1999; Treinies et al., 1999).”
BackgroundThe MAP kinase pathway is required for entry into mitosis and cell survival
Liu, X., Shi, Y., Zhou, T., Terada, Y., & Erikson, R. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207188 · Cited by 179 · cited 4×
“No Oncogene difference in the proliferation rate of ERK1-deficient embryonic fibroblasts was observed in a previous study (Pages et al., 1999), whereas RNAi silencing of ERK1 expression inhibited the proliferation of HeLa cells to the same extent as ERK2 silencing (Liu et al., 2004).”
BackgroundInfluentialWright, J. H., Munar, E., Jameson, D. R., Andreassen, P. R., Margolis, R. L., Seger, R., & Krebs, E. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11335 · Cited by 175 · cited 6×
“Although some studies have reported that ERK1/ERK2 are phosphorylated/activated during G2/M (Tamemoto et al., 1992; Edelmann et al., 1996; Wright et al., 1999; Roberts et al., 2002), others concluded that the kinases are inactivated in mitosis (Takenaka et al., 1998; Gomez-Cambronero, 1999; Hayne et al., 2000; Harding…”
BackgroundInfluentialServant, M. J., Giasson, E., & Meloche, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16047 · Cited by 171 · cited 4×
“So why does inhibition of ERK1/2 activity has such a profound effect on general protein synthesis (Servant et al., 1996)? One mechanism by which ERK1/ ERK2 may stimulate global mRNA translation is through enhancement of mammalian target of rapamycin (mTOR) signaling.”
BackgroundInfluentialSelf-citationBrondello, J., McKenzie, F. R., Sun, H., Tonks, N. K., & Pouysségur, J. (1995) · PubMed · Cited by 166
Self-citationTakuwa, N., & Takuwa, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5348 · Cited by 166 · cited 2×
“…signaling by synthetic MEK1/2 inhibitors or dominant-negative ERK2, or after conditional activation of the pathway by activated Raf-1 or MEK1 (Sewing et al., 1997; Takuwa and Takuwa, 1997; Weber et al., 1997a; Cheng et al., 1998; Ladha et al., 1998; Chen et al., 1999; Tetsu and McCormick, 2003).”
BackgroundResultCoding of neuronal differentiation by calcium transients
Spitzer, N. C., Lautermilch, N. J., Smith, R. D., & Gómez, T. M. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<811::aid-bies6>3.0.co;2-g · Cited by 164
Cooper, J. A., Sefton, B. M., & Hunter, T. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.1.30 · Cited by 164 · cited 1×
“…identified as mitogen-stimulated phosphoproteins of 41–45 kDa after separation by one- or two-dimensional gel electrophoresis (Nakamura et al., 1983; Cooper et al., 1984; Kohno, Correspondence: Dr S Meloche, Departments of Pharmacology and Molecular Biology, Institut de Recherche en Immunologie et…”
MethodInduction of Cell Proliferation in Quiescent NIH 3T3 Cells by Oncogenic c-Raf-1
Kerkhoff, E., & Rapp, U. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2576 · Cited by 162 · cited 1×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et…”
BackgroundSuzuki, T., Kawamura-Tsuzuku, J., Ajima, R., Nakamura, T., Yoshida, Y., & Yamamoto, T. S. (2002) · Genes & Development · doi:10.1101/gad.962802 · Cited by 161 · cited 4×
“ERK1/2 signaling also regulates Cyclin D1 transcription through phosphorylation and inactivation of Tob (Maekawa et al., 2002; Suzuki et al., 2002).”
BackgroundInfluentialDeletion of the p27 Kip1 gene restores normal development in cyclin D1-deficient mice
Geng, Y., Yu, Q., Sicinska, E., Das, M., Bronson, R. T., & Sicinski, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.194 · Cited by 153 · cited 2×
“A second non-catalytic function of cyclin D–Cdk4/6 complexes is to sequestrate the Cdk inhibitors p27 (p27) and p21 (p21) (Geng et al., 2001; Tong and Pollard, 2001).”
BackgroundCellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., Pérez De Castro, I., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 153 · cited 2×
“It should be noted that high-intensity ERK1/2 signaling induces the expression of the Cdk inhibitors p16 and p15 in certain cell lines, which can also contribute to cell cycle arrest (Malumbres et al., 2000; Han et al., 2005).”
BackgroundTamemoto, H., Kadowaki, T., Tobe, K., Ueki, K., Izumi, T., Chatani, Y., Kohno, M., Kasuga, M., Yazaki, Y., & Akanuma, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88700-8 · Cited by 151 · cited 5×
“Although some studies have reported that ERK1/ERK2 are phosphorylated/activated during G2/M (Tamemoto et al., 1992; Edelmann et al., 1996; Wright et al., 1999; Roberts et al., 2002), others concluded that the kinases are inactivated in mitosis (Takenaka et al., 1998; Gomez-Cambronero, 1999; Hayne et al., 2000; Harding…”
BackgroundInfluentialThe emerging roles of translation factor eIF4E in the nucleus
Strudwick, S., & Borden, K. L. B. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700102.x · Cited by 147 · cited 1×
“An important fraction of cellular eIF4E is found within the nucleus, where it associates with nuclear bodies (reviewed in Strudwick and Borden, 2002).”
BackgroundGysin, S., Lee, S.-H., Dean, N. M., & McMahon, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2848 · Cited by 147 · cited 2×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et a…”
BackgroundActivated Raf-1 causes growth arrest in human small cell lung cancer cells.
Ravi, R. K., Weber, E., McMahon, M., Williams, J. R., Baylin, S. B., Mal, A., Harter, M. L., Dillehay, L. E., Claudio, P. P., Giordano, A., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci831 · Cited by 145 · cited 1×
“It was even reported that activated Raf-1 markedly increases p27 expression in small cell lung cancer cell lines (Ravi et al., 1998).”
BackgroundCooperative Regulation of the Cell Division Cycle by the Protein Kinases RAF and AKT
Mirza, A. M., Gysin, S., Malek, N. P., Nakayama, K. I., Roberts, J. M., & McMahon, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10868-10881.2004 · Cited by 143 · cited 3×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et a…”
BackgroundRoberts, E. C., Shapiro, P. S., Nahreini, T. S., Pages, G., Pouyssegur, J., & Ahn, N. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7226-7241.2002 · Cited by 142 · cited 6×
“Although some studies have reported that ERK1/ERK2 are phosphorylated/activated during G2/M (Tamemoto et al., 1992; Edelmann et al., 1996; Wright et al., 1999; Roberts et al., 2002), others concluded that the kinases are inactivated in mitosis (Takenaka et al., 1998; Gomez-Cambronero, 1999; Hayne et al., 2000; Harding…”
BackgroundInfluentialSelf-citationMice lacking a transcriptional corepressor Tob are predisposed to cancer
Yoshida, Y., Nakamura, T., Komoda, M., Satoh, H., Suzuki, T., Kawamura-Tsuzuku, J., Miyasaka, T., Yoshida, E. H., Umemori, H., Kunisaki, R., et al. (2003) · Genes & Development · doi:10.1101/gad.1088003 · Cited by 137 · cited 2×
“Tob is a member of an emerging family of antiproliferative genes, which acts as a transcriptional co-repressor and negatively regulates Cyclin D1 transcription by recruiting histone deacetylase activity to the promoter (Yoshida et al., 2003).”
BackgroundBottazzi, M. E., Zhu, X., Böhmer, R. M., & Assoian, R. K. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.6.1255 · Cited by 136 · cited 1×
“In contrast to the induction of cyclin D1, a transient activation of ERK1/ERK2 is sufficient to induce the expression of p21 (Bottazzi et al., 1999).”
BackgroundAbbott, D. W., & Holt, J. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2732 · Cited by 131 · cited 1×
“The ERK1/2 pathway may also be involved in the G2 DNA damage checkpoint response (Abbott and Holt, 1999; Tang et al., 2002; Yan et al., 2005).”
BackgroundMorley, S. J., & McKendrick, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17887 · Cited by 127 · cited 1×
“At the same time, it was reported that treatment of cells with PD98059 drastically reduces insulin- and serum-induced phosphorylation of the translation initiation factor eIF4E (Flynn and Proud, 1996; Morley and McKendrick, 1997).”
BackgroundLenferink, A. E. G., Simpson, J. F., Shawver, L. K., Coffey, R. J., Forbes, J. T., & Arteaga, C. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160564197 · Cited by 125 · cited 2×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et a…”
BackgroundYang, H.-Y., Zhou, B. P., Hung, M., & Lee, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000147200 · Cited by 122 · cited 2×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et a…”
BackgroundNakamura, K. D., Martinez, R., & Weber, M. J. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.3.380 · Cited by 118
Kohno, M. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89660-0 · Cited by 111
Meloche, S. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041630319 · Cited by 107 · cited 3×
“…that mitogens induce a biphasic activation of ERK1 and ERK2 in fibroblasts, with a rapid and strong burst of kinase activity peaking at 5–10 min followed by a second wave of lower but sustained activity that persists throughout the G1 phase (Kahan et al., 1992; Meloche et al., 1992; Meloche, 1995).”
BackgroundSelf-citationEdelmann, H. M. L., Kühne, C., Petritsch, C., & Ballou, L. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.963 · Cited by 101 · cited 5×
“Although some studies have reported that ERK1/ERK2 are phosphorylated/activated during G2/M (Tamemoto et al., 1992; Edelmann et al., 1996; Wright et al., 1999; Roberts et al., 2002), others concluded that the kinases are inactivated in mitosis (Takenaka et al., 1998; Gomez-Cambronero, 1999; Hayne et al., 2000; Harding…”
BackgroundInfluentialRivard, N., Boucher, M.-J., Asselin, C., & L’Allemain, G. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.4.c652 · Cited by 100 · cited 2×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et a…”
BackgroundLai, H.-K., & Borden, K. L. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203473 · Cited by 99 · cited 1×
“…eIF4E functions to promote the nucleo-cytoplasmic export of a subset of growth-associated mRNAs including cyclin D1 (Rousseau et al., 1996; Lai and Borden, 2000; Topisirovic et al., 2002) by a mechanism involving an 100-nucleotide sequence in the 30 UTR of cyclin D1 mRNA (Culjkovic et…”
BackgroundHsc70 regulates accumulation of cyclin D1 and cyclin D1-dependent protein kinase
Diehl, J. A., Yang, W., Rimerman, R. A., Xiao, H., & Emili, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1764-1774.2003 · Cited by 97 · cited 2×
“This effect might be mediated by downstream phosphorylation of the chaperone Hsc70, which stabilizes newly synthesized cyclin D1 and helps assemble active cyclin D1–Cdk4 holoenzymes (Diehl et al., 2003).”
BackgroundRaf-1/MEK/MAPK Pathway Is Necessary for the G2/M Transition Induced by Nocodazole
Hayne, C., Tzivion, G., & Luo, Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002766200 · Cited by 96 · cited 3×
“…that ERK1/ERK2 are phosphorylated/activated during G2/M (Tamemoto et al., 1992; Edelmann et al., 1996; Wright et al., 1999; Roberts et al., 2002), others concluded that the kinases are inactivated in mitosis (Takenaka et al., 1998; Gomez-Cambronero, 1999; Hayne et al., 2000; Harding et al., 2003).”
BackgroundRegulation of Exit from Quiescence by p27 and Cyclin D1-CDK4
Ladha, M. H., Lee, K. Y., Upton, T. M., Reed, M. F., & Ewen, M. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6605 · Cited by 95 · cited 2×
“…signaling by synthetic MEK1/2 inhibitors or dominant-negative ERK2, or after conditional activation of the pathway by activated Raf-1 or MEK1 (Sewing et al., 1997; Takuwa and Takuwa, 1997; Weber et al., 1997a; Cheng et al., 1998; Ladha et al., 1998; Chen et al., 1999; Tetsu and McCormick, 2003).”
BackgroundResultKnauf, J. A., Ouyang, B., Knudsen, E. S., Fukasawa, K., Babcock, G., & Fagin, J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511690200 · Cited by 92 · cited 1×
“Inhibition of the ERK1/2 pathway by pharmacological or genetic approaches was reported to delay the G2/ M progression of cells (Wright et al., 1999; Hayne et al., 2000; Roberts et al., 2002; Liu et al., 2004; Knauf et al., 2006).”
An Analysis of Mek1 Signaling in Cell Proliferation and Transformation
Greulich, H. E., & Erikson, R. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13280 · Cited by 90 · cited 1×
“…signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et al., 2001; Mirza et…”
BackgroundGenetic Evidence for the Interactions of Cyclin D1 and p27Kip1 in Mice
Tong, W., & Pollard, J. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1319-1328.2001 · Cited by 88 · cited 1×
“A second non-catalytic function of cyclin D–Cdk4/6 complexes is to sequestrate the Cdk inhibitors p27Kip1 (p27) and p21Cip1 (p21) (Geng et al., 2001; Tong and Pollard, 2001).”
Backgroundp27 Kip1 and p21 Cip1 Are Not Required for the Formation of Active D Cyclin-cdk4 Complexes
Bagui, T. K., Mohapatra, S., Haura, E. B., & Pledger, W. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7285-7290.2003 · Cited by 87 · cited 1×
“The transient accumulation of p21 likely contributes to the stabilization of cyclin D–Cdk4 complexes in G1 (LaBaer et al., 1997; Cheng et al., 1999; Bagui et al., 2003).”
BackgroundMEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells
Willard, F. S., & Crouch, M. F. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00185-1 · Cited by 86 · cited 1×
“Immunofluorescence studies with phospho-specific antibodies also suggested that ERK1/ERK2 and MEK1/MEK2 are active in mitosis and localized at kinetochores, spindle poles and midbody Oncogene (Shapiro et al., 1998; Zecevic et al., 1998; Willard and Crouch, 2001; Liu et al., 2004).”
MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes
Karpova, A. Y., Abe, M. K., Li, J., Liu, P. T., Rhee, J. M., Kuo, W. L., & Hershenson, M. B. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.3.l558 · Cited by 86 · cited 2×
“Similarly, treatment with synthetic MEK1/2 inhibitors, which prevents activation of ERK1/ERK2, was reported to inhibit the proliferation of various cell types, including fibroblasts, T lymphocytes, smooth muscle cells, hepatocytes and epithelial cell lines (Dudley et al., 1995; Seufferlein et al., 1996; Karpova et al.…”
BackgroundRossomando, A. J., Sanghera, J. S., Marsden, L. A., Weber, M. J., Pelech, S., & Sturgill, T. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54918-8 · Cited by 83 · cited 1×
“This pair of tyrosine phosphorylated proteins was later shown to correspond to the activated forms of two MAP-2/myelin basic protein (MBP) kinases characterized previously and referred to as p42mapk (ERK2) and p44mapk (ERK1) (Rossomando et al., 1989, 1991).”
BackgroundBourcier, C., Jacquel, A., Hess, J., Peyrottes, I., Angel, P., Hofman, P., Auberger, P., Pouysségur, J., & Pagès, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3129 · Cited by 80 · cited 1×
“On the other hand, ERK1 deficiency was found to decrease the incidence and progression of skin papillomas in a two-stage mouse skin carcinogenesis model using 7,12-dimethylbenz(a)anthracene as initiator and 12-O-tetra-decanoyl-phorbol-13-acetate (TPA) as promoter (Bourcier et al., 2006).”
BackgroundSelf-citationIdentification of the Anti-proliferative Protein Tob as a MAPK Substrate
Maekawa, M., Nishida, E., & Tanoue, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204506200 · Cited by 77 · cited 4×
“ERK1/2 signaling also regulates Cyclin D1 transcription through phosphorylation and inactivation of Tob (Maekawa et al., 2002; Suzuki et al., 2002).”
BackgroundInfluentialDual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells
Boucher, M.-J., Jean, D., Vézina, A., & Rivard, N. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00453.2003 · Cited by 76 · cited 3×
“Expression of activated forms of Ras, Raf or MEK1 was shown to elicit cell cycle arrest in primary fibroblasts, Schwann cells, hepatocytes, T lymphocytes, keratinocytes, astrocytes and epithelial intestinal cells (Lloyd et al., 1997; Serrano et al., 1997; Lin et al., 1998; Tombes et al., 1998; Zhu et al., 1998; Chen e…”
BackgroundCOOKOnyx, S. J., & McCormick, F. P. (1996) · Biochemical Journal · doi:10.1042/bj3200237 · Cited by 75 · cited 1×
“These early observations were confirmed by several laboratories using different cellular models (Cook and McCormick, 1996; Weber et al., 1997b; Talarmin et al., 1999; Jones and Kazlauskas, 2001), allowing the generalization of the model.”
ResultHigh-intensity Raf signals convert mitotic cell cycling into cellular growth.
Kerkhoff, E., & Rapp, U. R. (1998) · PubMed · Cited by 75
Dey, A., She, H., Kim, L., Boruch, A., Guris, D. L., Carlberg, K., Sebti, S. M., Woodley, D. T., Imamoto, A., & Li, W. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.11.3835 · Cited by 72 · cited 1×
“Although ERK1/2 signaling has been mainly associated with the induction of cyclin D1, there are a few reports implicating this pathway in the regulation of cyclin D2 (Dey et al., 2000; Piatelli et al., 2002) and cyclin D3 (Tetsu and McCormick, 2003) expression.”
BackgroundPiatelli, M. J., Doughty, C., & Chiles, T. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200102200 · Cited by 72 · cited 1×
“Although ERK1/2 signaling has been mainly associated with the induction of cyclin D1, there are a few reports implicating this pathway in the regulation of cyclin D2 (Dey et al., 2000; Piatelli et al., 2002) and cyclin D3 (Tetsu and McCormick, 2003) expression.”
BackgroundDual Growth Arrest Pathways in Astrocytes and Astrocytic Tumors in Response to Raf-1 Activation
Fanton, C. P., McMahon, M., & Pieper, R. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011514200 · Cited by 71 · cited 5×
“In normal human astrocytes with an intact p16Ink4a/Rb pathway, activated Raf-1 induces an irreversible senescence-like proliferation arrest associated with upregulation of p16Ink4a expression (Fanton et al., 2001).”
BackgroundInfluentialArber, N., Sutter, T., Miyake, M., Kahn, S. M., Venkatraj, V. S., Sobrino, A., Warburton, D., Holt, P. R., & Weinstein, I. B. (1996) · PubMed · Cited by 71
Delmas, C., Manenti, S., Boudjelal, A., Peyssonnaux, C., Eychène, A., & Darbon, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101714200 · Cited by 67 · cited 3×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et a…”
BackgroundBRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation
Yan, Y., Spieker, R. S., Kim, M., Stoeger, S. M., & Cowan, K. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208492 · Cited by 65 · cited 1×
“The ERK1/2 pathway may also be involved in the G2 DNA damage checkpoint response (Abbott and Holt, 1999; Tang et al., 2002; Yan et al., 2005).”
BackgroundRas versus cyclin-dependent kinase inhibitors
Lloyd, A. C. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80060-9 · Cited by 64 · cited 1×
“It has been proposed that induction of Cdk inhibitors in response to abnormal mitogenic signaling and the resulting cell cycle arrest is a crucial mechanism for protection against cancer development Oncogene (Serrano et al., 1997; Lloyd, 1998).”
BackgroundMechanism of Mitosis-specific Activation of MEK1
Harding, A. S., Giles, N., Burgess, A., Hancock, J. F., & Gabrielli, B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301015200 · Cited by 64 · cited 2×
“…that ERK1/ERK2 are phosphorylated/activated during G2/M (Tamemoto et al., 1992; Edelmann et al., 1996; Wright et al., 1999; Roberts et al., 2002), others concluded that the kinases are inactivated in mitosis (Takenaka et al., 1998; Gomez-Cambronero, 1999; Hayne et al., 2000; Harding et al., 2003).”
BackgroundTopisirović, I., Capili, A. D., & Borden, K. L. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6183-6198.2002 · Cited by 61 · cited 2×
“…eIF4E functions to promote the nucleo-cytoplasmic export of a subset of growth-associated mRNAs including cyclin D1 (Rousseau et al., 1996; Lai and Borden, 2000; Topisirovic et al., 2002) by a mechanism involving an 100-nucleotide sequence in the 30 UTR of cyclin D1 mRNA (Culjkovic et al., 2005).”
Backgroundp19 ARF ‐independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes
Roper, E., Weinberg, W., Watt, F. M., & Land, H. (2001) · EMBO reports · doi:10.1093/embo-reports/kve020 · Cited by 59 · cited 2×
“Expression of activated forms of Ras, Raf or MEK1 was shown to elicit cell cycle arrest in primary fibroblasts, Schwann cells, hepatocytes, T lymphocytes, keratinocytes, astrocytes and epithelial intestinal cells (Lloyd et al., 1997; Serrano et al., 1997; Lin et al., 1998; Tombes et al., 1998; Zhu et al., 1998; Chen e…”
BackgroundInterwoven Ubiquitination Oscillators and Control of Cell Cycle Transitions
Ang, X. L., & Harper, J. W. (2004) · Science s STKE · doi:10.1126/stke.2422004pe31 · Cited by 58 · cited 1×
“Finally, Cdk2 phosphorylates and inactivates the anaphase-promoting complex (APC)-activating subunit Cdh1, which targets a number of S-phase-promoting factors for degradation (Peters, 2002; Ang and Harper, 2004).”
BackgroundSustained Activation of the Raf-MEK-ERK Pathway Elicits Cytokine Unresponsiveness in T Cells
Chen, D., Heath, V., O’Garra, A., Johnston, J., & McMahon, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5796 · Cited by 58 · cited 5×
“In contrast, other studies failed to document any significant change in p27 levels following inhibition of ERK1/2 signaling by synthetic MEK1/2 inhibitors or dominant-negative ERK2, or after conditional activation of the pathway by activated Raf-1 or MEK1 (Sewing et al., 1997; Takuwa and Takuwa, 1997; Weber et al., 19…”
BackgroundResultInfluentialHan, J., Tsukada, Y.-I., Hara, E., Kitamura, N., & Tanaka, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503431200 · Cited by 57 · cited 2×
“It should be noted that high-intensity ERK1/2 signaling induces the expression of the Cdk inhibitors p16 and p15 in certain cell lines, which can also contribute to cell cycle arrest (Malumbres et al., 2000; Han et al., 2005).”
BackgroundKohno, M., & Pouysségur, J. (1986) · Biochemical Journal · doi:10.1042/bj2380451 · Cited by 54 · cited 1×
“E-mails: jacques.pouyssegur@unice.fr or sylvain.meloche@umontreal.ca Oncogene (2007) 26, 3227–3239 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc 1985; Kohno and Pouyssegur, 1986).”
BackgroundInfluentialSelf-citationZezula, J., Sexl, V., Hutter, C., Karel, A., Schütz, W., & Freissmuth, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29967 · Cited by 52 · cited 1×
“This induction of p21 is dependent on ERK1/2 signaling and is exerted, at least in part, at the level of transcription (Liu et al., 1996; Zezula et al., 1997).”
BackgroundCha, H., Hancock, C. N., Dangi, S., Maiguel, D. A., Carrier, F., & Shapiro, P. S. (2004) · Biochemical Journal · doi:10.1042/bj20031173 · Cited by 51 · cited 1×
“However, more recent studies have shown that phospho-specific antibodies to MEK1/MEK2 strongly cross-react with phosphorylated nucleophosmin, a multifunctional nuclear phosphoprotein involved in centrosome duplication (Cha et al., 2004; Hayne et al., 2004).”
BackgroundWilliams, D. H., Wilkinson, S. E., Purton, T., Lamont, A. G., Flotow, H., & Murray, E. J. (1998) · Biochemistry · doi:10.1021/bi972914c · Cited by 51 · cited 1×
“…of various cell types, including fibroblasts, T lymphocytes, smooth muscle cells, hepatocytes and epithelial cell lines (Dudley et al., 1995; Seufferlein et al., 1996; Karpova et al., 1997; DeSilva et al., 1998; Williams et al., 1998; SeboltLeopold et al., 1999; Talarmin et al., 1999).”
BackgroundSeufferlein, T. T. W., Withers, D. J., & Rozengurt, E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21471 · Cited by 50 · cited 2×
“Similarly, treatment with synthetic MEK1/2 inhibitors, which prevents activation of ERK1/ERK2, was reported to inhibit the proliferation of various cell types, including fibroblasts, T lymphocytes, smooth muscle cells, hepatocytes and epithelial cell lines (Dudley et al., 1995; Seufferlein et al., 1996; Karpova et al.…”
BackgroundFlynn, A., & Proud, C. G. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00040.x · Cited by 43 · cited 1×
“At the same time, it was reported that treatment of cells with PD98059 drastically reduces insulin- and serum-induced phosphorylation of the translation initiation factor eIF4E (Flynn and Proud, 1996; Morley and McKendrick, 1997).”
BackgroundPDGF-BB Regulates p27 Expression through ERK-dependent RNA Turn-over inVascular Smooth MuscleCells
Sakakibara, K., Kubota, K., Worku, B., Ryer, E. J., Miller, J. P., Koff, A., Kent, K. C., & Liu, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502320200 · Cited by 41 · cited 2×
“Several studies have suggested that the Ras–ERK1/2 signaling pathway is involved in the mitogen-induced downregulation of p27 (Kawada et al., 1997; Kerkhoff and Rapp, 1997; Woods et al., 1997; Greulich and Erikson, 1998; Rivard et al., 1999; Treinies et al., 1999; Lenferink et al., 2000; Yang et al., 2000; Delmas et a…”
BackgroundShinohara, M., Mikhailov, A. V., Aguirre‐Ghiso, J. A., & Rieder, C. L. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-04-0284 · Cited by 32 · cited 3×
“…regions, centrosomes and midbodies observed with the phospho-ERK1/2 antibody could not be blocked by pretreatment with the MEK1/2 inhibitor U0126, although the drug completely suppressed the weak phospho-ERK1/2 signal observed by immunoblot analysis in mitotic cells (Shinohara et al., 2006).”
BackgroundControl of the Cell Morphology and the S Phase Entry by Mitogen-activated Protein Kinase Kinase
Gotoh, I., Fukuda, M., Adachi, M., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11874 · Cited by 30 · cited 2×
“The addition of insulin to serum-free culture medium (Gotoh et al., 1999) may also lead to confounding results, as insulin is able to substitute for (PI(3)K) lipid products in late G1 (Jones and Kazlauskas, 2001).”
Backgroundp42‐MAP kinase is activated in EGF‐stimulated interphase but not in metaphase‐arrested HeLa cells
Gómez-Cambronero, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01685-8 · Cited by 15 · cited 2×
“…that ERK1/ERK2 are phosphorylated/activated during G2/M (Tamemoto et al., 1992; Edelmann et al., 1996; Wright et al., 1999; Roberts et al., 2002), others concluded that the kinases are inactivated in mitosis (Takenaka et al., 1998; Gomez-Cambronero, 1999; Hayne et al., 2000; Harding et al., 2003).”
BackgroundMEK inhibition and phosphorylation of serine 4 on B23 are two coincident events in mitosis
Hayne, C. C., Xiang, X., & Luo, Z. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.024 · Cited by 11 · cited 1×
“However, more recent studies have shown that phospho-specific antibodies to MEK1/MEK2 strongly cross-react with phosphorylated nucleophosmin, a multifunctional nuclear phosphoprotein involved in centrosome duplication (Cha et al., 2004; Hayne et al., 2004).”
Background
Cited by
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Mendoza, M. C., Er, E. E., & Blenis, J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.03.006 · Cited by 1,817
“Confoundingly, non-physiological hyper-activation of Ras-ERK signaling can induce the expression of CDK (cyclin-dependent kinase) inhibitors and trigger cell cycle arrest [5].”
BackgroundMitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
“The ERK MAPKs are regulated by the upstream MEK kinase (MAPK kinase) and at low levels induce cellular proliferation but at high levels cause growth arrest (18).”
BackgroundPhysiology of cell volume regulation in vertebrates
Hoffmann, E. K., Lambert, I. H., & Pedersen, S. F. (2009) · Physiological Reviews · doi:10.1152/physrev.00037.2007 · Cited by 1,441
Oxidative Stress in Aging Human Skin
Rinnerthaler, M., Bischof, J., Streubel, M., Trost, A., & Richter, K. (2015) · Biomolecules · doi:10.3390/biom5020545 · Cited by 1,053
“The tumor suppressor Rb is then in a complex with the E2F transcription factors, resulting in an inhibition of E2F target genes and a cell cycle arrest [343,345–351].”
Background
Metadata
- Authors
- Meloche, S., & Pouysségur, J.
- Affiliations
- Institute for Research in Immunology and Cancer (CA)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Meloche, S
- Pouysségur, J
- Venue
- Oncogene
- Published
- 2007-05-14
- Volume
- 26
- Issue
- 22
- Pages
- 3227-3239
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1983833034
- Cited by
- 1,091
- References
- 194
- Citations by year
- 2026: 31 · 2025: 26 · 2024: 35 · 2023: 43 · 2022: 47 · 2021: 65 · 2020: 54 · 2019: 58 · 2018: 60 · 2017: 68 · 2016: 48 · 2015: 61 · 2014: 69 · 2013: 68 · 2012: 79
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- ERK1/2, MAPK signaling, Ras signaling, G1/S transition, cell cycle progression, cell proliferation, cyclin-dependent kinase inhibitors, cell cycle arrest, Raf activation, somatic cells
- MeSH terms
- Animals, Enzyme Activation, Humans, G1 Phase, S Phase, Mitogen-Activated Protein Kinase 1, MAP Kinase Signaling System, Mitogen-Activated Protein Kinase 3, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.